3-Bromopropyne | CAS:106-96-7

We serve 3-Bromopropyne CAS:106-96-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromopropyne

Chemical Name: 3-Bromopropyne
CAS.NO:106-96-7
Synonyms: 
3-Bromopropyne
1-Propyne, 3-bromo-
3-bromoprop-1-yne
3-Bromo-1-propyne
Propargyl bromide
 
Molecular Formula:C3H3Br
Molecular Weight:118.96000
 
Physical and Chemical Properties:
Density:1.38 g/mL at 20 °C
Boiling point:97 °C
Melting point:-61°C
Flash point:65 °F
Index of Refraction:1.494
 
Specification:
Appearance:Transparent to yellow liquid
Purity:≥99.0%
 
Packing:25kg/drum, can also be packaged according to customer requirements
Storage:The warehouse is ventilated and dry at low temperature, and stored separately from the oxidant.
Application:It is used to synthesize various derivatives of acetylene; the pharmaceutical industry is used to make the antifungal drug chloropropyne iodine. Applicationd in the manufacture of propyne amines (enyne replacement)



Contact us for information like 3-Bromopropyne chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propargyl bromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromopropyne Use and application,3-bromoprop-1-yne technical grade,usp/ep/jp grade.


Related News: New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country.9-(2-BroMo-phenyl)-9-phenyl-9H-fluorene manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.1-bromo-2-(bromomethyl)benzene supplier The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.(1S,2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene vendor The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.